The intrapleural route involves the direct administration of medication into the pleural space, which is the fluid-filled area between the visceral and parietal pleura surrounding the lungs. This specialized route allows clinicians to deliver drugs locally to the pleural cavity, achieving high local concentrations while minimizing systemic side effects. It is frequently utilized in settings such as critical care, pulmonology, and cardiothoracic surgery for targeted therapeutic interventions.
Understanding chest wall anatomy is vital for safe intrapleural drug delivery. The pleural space normally contains a thin film of lubricating fluid that facilitates smooth lung movement during respiration. When medications are instilled here, absorption occurs across the large surface area of the pleural membranes into the local microvasculature. Pathological conditions like pleural effusions, empyema, or adhesions can alter this space, affecting how drugs spread and are absorbed.
Intrapleural therapy is indicated for specific thoracic pathologies that require localized intervention.
Administering intrapleural medication requires strict aseptic technique to prevent iatrogenic empyema. The drug is typically introduced through an existing chest tube or via thoracentesis. When using a chest tube, the nurse often clamps the tube for a prescribed period after instillation to allow the medication to dwell in contact with the pleural surfaces. The patient may be repositioned periodically to ensure the solution coats all areas of the pleural cavity.
Nurses play a crucial role in monitoring patients receiving intrapleural therapies. Vital signs must be recorded frequently to detect early signs of systemic absorption toxicity, infection, or hemorrhage. The nurse assesses respiratory status, observing for changes in breath sounds, oxygen saturation, and work of breathing. Pain levels are evaluated regularly, especially when local anesthetics or sclerosing agents—which cause significant pleuritic chest discomfort—are used.
Although beneficial, intrapleural therapy carries risks such as fever, chest pain, bleeding, and secondary bacterial infection. Systemic toxicity can also occur if local anesthetics are rapidly absorbed through highly vascularized pleural tissue. Nurses must ensure emergency equipment is nearby, monitor chest tube output closely for signs of hemorrhage, and report abnormal clinical findings without delay.